Microbot Historical Cash Flow
| MBOT Stock | USD 0.99 0.01 1.02% |
Analysis of Microbot Medical cash flow over time is an excellent tool to project Microbot Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 753.9 K or Capital Expenditures of 31.4 K as it is a great indicator of Microbot Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Microbot Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Microbot Medical is a good buy for the upcoming year.
Microbot |
About Microbot Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Microbot balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Microbot's non-liquid assets can be easily converted into cash.
Microbot Medical Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Microbot Medical to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Microbot Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Most accounts from Microbot Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Microbot Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.At this time, Microbot Medical's Other Non Cash Items is comparatively stable compared to the past year. Total Cash From Financing Activities is likely to gain to about 11.2 M in 2024, despite the fact that Change In Working Capital is likely to grow to (10.4 K).
Microbot Medical cash flow statement Correlations
Click cells to compare fundamentals
Microbot Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Microbot Medical cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 27.9M | (13.4M) | (6.2M) | (11.1M) | (2K) | (1.9K) | |
| Free Cash Flow | (6.7M) | (7.3M) | (9.4M) | (11.6M) | (8.6M) | (9.0M) | |
| Change In Working Capital | (266K) | (18K) | 497K | (228K) | (11K) | (10.5K) | |
| Begin Period Cash Flow | 5.3M | 33.1M | 19.7M | 13.6M | 2.5M | 2.4M | |
| Other Cashflows From Financing Activities | 36.8K | (3.4M) | 3.2M | (3.8M) | 2.0M | 1.9M | |
| Depreciation | 84K | 68K | 76K | 102K | 106K | 100.7K | |
| Other Non Cash Items | (25K) | (70K) | 1.5M | (7K) | 718K | 753.9K | |
| Capital Expenditures | 216K | 91K | 69K | 84K | 33K | 31.4K | |
| Total Cash From Operating Activities | (6.5M) | (7.3M) | (9.4M) | (11.5M) | (8.5M) | (9.0M) | |
| Net Income | (7.2M) | (9.2M) | (11.3M) | (13.2M) | (10.7M) | (11.3M) | |
| Total Cash From Financing Activities | (18K) | 36.8M | (3.4K) | 4.3M | 6.6M | 11.2M | |
| End Period Cash Flow | 33.1M | 19.7M | 13.6M | 2.5M | 2.5M | 2.4M | |
| Stock Based Compensation | 1.1M | 1.9M | 1.4M | 1.8M | 1.4M | 1.3M | |
| Investments | (2.5M) | (2.8M) | 3.2M | (3.8M) | (4.7M) | (5.0M) | |
| Total Cashflows From Investing Activities | (223K) | (2.5M) | (2.8M) | 3.2M | 3.7M | 3.9M | |
| Cash And Cash Equivalents Changes | 8.1M | (5.6M) | 27.9M | (13.4M) | (15.4M) | (14.6M) | |
| Cash Flows Other Operating | 237K | 74K | (151K) | 152K | 174.8K | 166.1K | |
| Change To Netincome | 1.4M | 1.0M | 1.9M | 1.4M | 1.2M | 1.5M | |
| Change To Liabilities | (140K) | (240K) | 320K | (241K) | (216.9K) | (206.1K) | |
| Change To Operating Activities | (126K) | 222K | 177K | 13K | 15.0K | 20.9K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.